Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000116547 | SCV000301899 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000116547 | SCV000527059 | benign | not specified | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001085863 | SCV000645519 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711023 | SCV000841341 | benign | not provided | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000711023 | SCV005214521 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116547 | SCV000150504 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV001085863 | SCV001454330 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |